|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.5 EUR | +1.12% |
|
-0.75% | +15.54% |
| May. 30 | Merck KGaA: memorandum of understanding with South Korean institute | CF |
| May. 30 | Merck KGaA Signs Korea Science Research Pact | DJ |
Merck KGaA reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was EUR 5,120 million compared to EUR 5,293 million a year ago. Net income was EUR 694 million compared to EUR 796 million a year ago.
Basic earnings per share from continuing operations was EUR 1.6 compared to EUR 1.83 a year ago. Diluted earnings per share from continuing operations was EUR 1.6 compared to EUR 1.83 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.54% | 77.63B | |
| +12.05% | 8.78B | |
| +58.17% | 4.93B | |
| -14.94% | 4.79B | |
| -.--% | 3.8B | |
| +21.94% | 2.46B | |
| -26.63% | 2.2B | |
| +16.75% | 2.1B | |
| -37.97% | 1.96B | |
| -0.50% | 1.64B |
MERCK KGAA 
